Table 3.
Variable | Categorization | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
P value | HR | 95% CI | P value | ||
Sex | female, male | 0.929 | |||
Age | ≤56, >56 | 0.424 | |||
HBsAg | negative, positive | 0.035* | |||
intrahepatic biliary stones | negative, positive | 0.421 | |||
Tumour diameter, cm | ≤5, >5 | 0.193 | |||
Surgical procedure | nonanatomical, anatomical | 0.607 | |||
Complications | 0.250 | ||||
No complication | |||||
Clavien-Dindo grade I-II | |||||
Clavien-Dindo grade III-IV | |||||
Tumour differentiation | poor, others | 0.116 | |||
Vascular invasion | absent, present | 0.074 | |||
Perineural invasion | absent, present | 0.896 | |||
Periductal invasion | absent, present | 0.852 | |||
Surgical margin | negative, positive | 0.658 | |||
Lymph node metastasis | absent, present | 0.119 | |||
Pathological cirrhosis | absent, present | 0.629 | |||
antiviral therapy | no, yes | 0.436 | |||
Adjuvant therapy | no, yes | 0.006* | 0.757 | 0.605–0.949 | 0.016* |
* indicates statistically significant.
DFS, disease-free survival; HBsAg, hepatitis B virus surface antigen; HR, hazard ratio; ICC, intrahepatic cholangiocarcinoma.